P-гликопротеин, или ABCB1 (ATP-binding cassette sub-family B member 1; CD243) — мембранный белок, гликопротеин из семейства ABC-переносчиков. Обеспечивает перенос многих веществ, таких как липиды, стероиды, пептиды, билирубин и др., через мембрану клетки.

Библиография

• Ling V (1997). «Multidrug resistance: molecular mechanisms and clinical relevance». Cancer Chemother. Pharmacol. 40 Suppl (7): S3–8. 10.1007/s002800051053. PMID 9272126.
• Kerb R, Hoffmeyer S, Brinkmann U (2001). «ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2». Pharmacogenomics 2 (1): 51–64. 10.1517/14622416.2.1.51. PMID 11258197.
• Akiyama S (2002). «[Mechanisms of drug resistance and reversal of the resistance]». Hum. Cell 14 (4): 257–60. PMID 11925925.
• Brinkmann U (2002). «Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo». Novartis Found. Symp. 243: 207–10; discussion 210–2, 231–5. 10.1002/0470846356.ch15. PMID 11990778.
• Váradi A, Szakács G, Bakos E, Sarkadi B (2002). «P glycoprotein and the mechanism of multidrug resistance». Novartis Found. Symp. 243: 54–65; discussion 65–8, 180–5. 10.1002/0470846356.ch5. PMID 11990782.
• Hegedus T, Orfi L, Seprodi A, et al. (2002). «Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1». Biochim. Biophys. Acta 1587 (2–3): 318–25. PMID 12084474.
• Pallis M, Turzanski J, Higashi Y, Russell N (2003). «P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype». Leuk. Lymphoma 43 (6): 1221–8. 10.1080/10428190290026277. PMID 12152989.
• Schaich M, Illmer T (2003). «Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia». Leuk. Lymphoma 43 (7): 1345–54. 10.1080/10428190290033279. PMID 12389613.
• Fromm MF (2003). «The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans». Adv. Drug Deliv. Rev. 54 (10): 1295–310. 10.1016/S0169-409X(02)00064-9. PMID 12406646.
• Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, 10.1038/sj.onc.1206948. PMID 14576852.
• Jamroziak K, Robak T (2004). «Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies». Hematology 9 (2): 91–105. 10.1080/10245330310001638974. PMID 15203864.
• Ishikawa T, Onishi Y, Hirano H, et al. (2005). «Pharmacogenomics of drug transporters: a new approach to functional analysis of the genetic polymorphisms of ABCB1 (P-glycoprotein/MDR1)». Biol. Pharm. Bull. 27 (7): 939–48. 10.1248/bpb.27.939. PMID 15256718.
• Lee W, Lockhart AC, Kim RB, Rothenberg ML (2005). «Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development». Oncologist 10 (2): 104–11. 10.1634/theoncologist.10-2-104. PMID 15709212.
• Gambrelle J, Labialle S, Dayan G, et al. (2005). «[Multidrug resistance in uveal melanoma.]». Journal français d'ophtalmologie 28 (6): 652–9. PMID 16141933.
• Al-Shawi MK, Omote H (2006). «The Remarkable Transport Mechanism of P-glycoprotein; a Multidrug Transporter». J. Bioenerg. Biomembr. 37 (6): 489–96. 10.1007/s10863-005-9497-5. PMID 16691488.
• Orlowski S, Martin S, Escargueil A (2006). «P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?)». Cell. Mol. Life Sci. 63 (9): 1038–59. 10.1007/s00018-005-5554-9. PMID 16721513.
• Annese V, Valvano MR, Palmieri O, et al. (2006). «Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis». World J. Gastroenterol. 12 (23): 3636–44. PMID 16773678.
• Sekine I, Minna JD, Nishio K, et al. (2007). «A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer». Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 1 (1): 31–7. PMID 17409824.
• Kumar YS, Adukondalu D, Sathish D, Vishnu YV, Ramesh G, Latha AB, Reddy PC, Sarangapani M, Rao YM (2010). «P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions». Drug Metabol Drug Interact 25 (1-4): 3–16. 10.1515/DMDI.2010.006. PMID 21417789.